Initial Management: Cognitive Behavioral Therapy for Insomnia (CBT-I)
This 24-year-old should receive cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, which can be delivered in-person, via telephone, web-based modules, or self-help books 1.
Assessment First
Before initiating treatment, evaluate for:
- Sleep disorders that mimic insomnia: sleep apnea, restless legs syndrome, periodic limb movement disorder 2
- Contributing medications: review all current medications
- Medical conditions: chronic pain, respiratory problems, endocrine disorders
- Psychiatric comorbidities: anxiety, depression (though insomnia warrants treatment regardless of comorbidity)
- Substance use: caffeine timing/amount, alcohol, nicotine 3
Important consideration for this patient: The weekend sleep pattern (later bedtime, later wake time) suggests possible delayed sleep phase disorder rather than pure insomnia 4. This is common in young adults and involves a circadian rhythm shift, not just difficulty sleeping. However, the perceived 5-hour sleep duration on weekdays with an 8-hour time-in-bed window (11:40 pm to 7:40 am) suggests true insomnia with prolonged sleep onset latency or wake after sleep onset.
Why CBT-I First
CBT-I is a strong recommendation with moderate-quality evidence for improving:
- Sleep onset latency (time to fall asleep)
- Wake after sleep onset
- Sleep efficiency
- Sleep quality
- Global functioning and quality of life 1
The therapy combines:
- Sleep restriction therapy: Limiting time in bed to actual sleep time (initially ~5 hours based on patient's report), then gradually increasing as sleep efficiency improves
- Stimulus control: Strengthening the bed-sleep association, establishing consistent sleep-wake times
- Cognitive therapy: Addressing maladaptive thoughts about sleep and worry
- Sleep hygiene education: Optimizing the sleep environment and behaviors 3
Delivery Options
Multiple effective formats exist 1:
- Individual face-to-face therapy
- Group therapy
- Telephone-based
- Web-based/digital programs
- Self-help books
Digital CBT-I is explicitly recommended as first-line treatment 2, making access easier for a 24-year-old who may prefer this modality.
If CBT-I Fails
Only after CBT-I proves insufficient should pharmacotherapy be considered through shared decision-making, discussing benefits, harms, and costs 1. Medications should be used short-term (≤4 weeks for most agents) 1, 2:
Evidence-based options include:
- Orexin receptor antagonists (suvorexant, daridorexant): Can be used up to 3 months or longer, moderate-quality evidence 1, 2
- Low-dose doxepin: Improves sleep onset and maintenance 1, 5
- Eszopiclone or zolpidem: Effective but FDA recommends short-term use due to risks of cognitive impairment, falls, fractures, and driving impairment 1
Avoid as routine treatment:
- Antihistamines (diphenhydramine)
- Benzodiazepines for long-term use
- Antipsychotics
- Fast-release melatonin 2
Critical Pitfalls
- Do not start with medications: Sleep medications have serious adverse effects including dementia risk, fractures, motor vehicle accidents, and "sleep driving" 1
- Do not overlook circadian rhythm disorders: This patient's weekend pattern warrants consideration of delayed sleep phase disorder, which may benefit from morning bright light therapy and chronotherapy in addition to CBT-I 4
- Do not use sleep hygiene education alone: It is ineffective as monotherapy 3
- Do not prescribe medications long-term without reassessment: FDA approval is for 4-5 weeks 1
Practical Algorithm
- Confirm insomnia diagnosis: Symptoms ≥3 nights/week for ≥3 months with daytime impairment
- Rule out sleep disorder mimics: Consider sleep study if sleep apnea suspected
- Initiate CBT-I: Choose delivery method based on patient preference and access
- Reassess in 4-8 weeks: Most patients respond to CBT-I
- If inadequate response: Add short-term pharmacotherapy via shared decision-making
- Monitor medication use: Taper and discontinue within 4-6 weeks when possible